Sakaguchi Shimon, Wing Kajsa, Onishi Yasushi, Prieto-Martin Paz, Yamaguchi Tomoyuki
Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan.
Int Immunol. 2009 Oct;21(10):1105-11. doi: 10.1093/intimm/dxp095. Epub 2009 Sep 7.
Regulatory T cells (Tregs), either natural or induced, suppress a variety of physiological and pathological immune responses. One of the key issues for understanding Treg function is to determine how they suppress other lymphocytes at the molecular level in vivo and in vitro. Here we propose that there may be a key suppressive mechanism that is shared by every forkhead box p3 (Foxp3)(+) Treg in vivo and in vitro in mice and humans. When this central mechanism is abrogated, it causes a breach in self-tolerance and immune homeostasis. Other suppressive mechanisms may synergistically operate with this common mechanism depending on the environment and the type of an immune response. Further, Treg-mediated suppression is a multi-step process and impairment or augmentation of each step can alter the ultimate effectiveness of Treg-mediated suppression. These findings will help to design effective ways for controlling immune responses by targeting Treg suppressive functions.
调节性T细胞(Tregs),无论是天然的还是诱导产生的,都能抑制多种生理和病理免疫反应。理解Treg功能的关键问题之一是确定它们在体内和体外如何在分子水平上抑制其他淋巴细胞。在此我们提出,在小鼠和人类体内及体外,每个叉头框p3(Foxp3)(+) Treg可能都存在一种关键的抑制机制。当这种核心机制被破坏时,会导致自身耐受和免疫稳态的破坏。根据环境和免疫反应的类型,其他抑制机制可能与这种共同机制协同发挥作用。此外,Treg介导的抑制是一个多步骤过程,每个步骤的损伤或增强都可能改变Treg介导抑制的最终效果。这些发现将有助于通过靶向Treg抑制功能来设计控制免疫反应的有效方法。